Emerging industries, from crypto to AI to life sciences, pose unique challenges in damages arbitration. With limited track records, high volatility, and evolving regulatory landscapes, tribunals face tough questions around valuation, risk, and fairness. This panel explores how to approach damages when traditional models fall short, and what practical tools and frameworks can help navigate uncertainty in fast-moving sectors.

Expect discussion on:

• How do tribunals assess damages when companies lack revenue or performance benchmarks?
• Crypto assets – valuation and awarding damages in cryptocurrency
• Valuing pharmaceutical products still under development
• Where to start with a damages claim in a dispute over AI technology